Efficacy of a Dietary Supplement on Parameters of Skin Aging in Men and Women

NCT ID: NCT06083402

Last Updated: 2023-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

63 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-12

Study Completion Date

2023-10-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As the body ages, the skin experiences natural changes in structure and composition. These changes may manifest visibly as increased skin dryness, wrinkling, and a loss of firmness/elasticity. In this double-blind, randomized, placebo-controlled trial, the investigators will recruit healthy men and women with mild to moderate signs of skin aging and randomly assign them to either receive a HyaCera™ or placebo for 12 weeks. The investigators will perform a series of objective and subjective measurements to assess changes in skin condition. The investigators hypothesize that consumption of HyaCera™ leads to improvements in the general condition of the skin including skin hydration, crow's feet wrinkling, and other skin aging parameters.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Healthy men and women with mild to moderate signs of skin aging will be randomly assigned to either receive a Ritual HyaCera or placebo for 12 weeks
Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators
Neither the participants nor the investigators will know the group assignment. Supplements will be prepared by the sponsor and marked with unidentifiable ID numbers before being sent to study site.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active

Participants receive 1 HyaCera™ capsule orally once daily for 12 weeks

Group Type ACTIVE_COMPARATOR

HyaCera™

Intervention Type DIETARY_SUPPLEMENT

1 Ritual HyaCera capsule once daily

Placebo

Participants receive 1 placebo capsule orally once daily for 12 weeks

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

1 placebo capsule once daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HyaCera™

1 Ritual HyaCera capsule once daily

Intervention Type DIETARY_SUPPLEMENT

Placebo

1 placebo capsule once daily

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy male and female volunteers, 25 - 70 years old with mild to moderate fine lines and wrinkles
* All ethnicities and skin types
* Willing to maintain current skincare regimen on face, arms, and legs and withhold all facial and body treatments throughout the course of the study

Exclusion Criteria

* Self-reported pregnant or breastfeeding or planning to become pregnant during the course of the study
* Any conditions on the face, arms and legs that would interfere with evaluations
* Under treatment for any known health issues/medical conditions including chronic health conditions and skin diseases/conditions
Minimum Eligible Age

25 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Natals, Inc. dba Ritual

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Princeton Consumer Research

Raritan, New Jersey, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Grier-Welch AM, Vance AY, Alamdari N, Sharafi M. Efficacy of an Oral Skincare Supplement on Skin Aging: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial. Dermatol Ther (Heidelb). 2025 Oct 10. doi: 10.1007/s13555-025-01556-2. Online ahead of print.

Reference Type DERIVED
PMID: 41071523 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HyaCera2023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

RHA Redensity - Perioral Rhytids
NCT03092219 COMPLETED NA